COMPANY PROFILE · UPDATED 18 NOV 2025

Be Biopharma

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.

be.bio ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2020
Headcount: 71
Open roles: 0
Last raised: Series C · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Be Biopharma

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$356,000,000

Investors

Alta PartnersArch Venture PartnersAtlas VentureBristol Myers SquibbLongwood FundNextech InvestRA Capital ManagementTakeda Ventures

Funding rounds

Series C
Bristol Myers Squibb, Longwood Fund, Nextech Invest, Arch Venture Partners, Atlas Venture, Alta Partners, RA Capital Management, Takeda Ventures
$92MJan 14, 2025
Series Unknown
Arch Venture Partners, Takeda Ventures, RA Capital Management, Atlas Venture, Alta Partners, Bristol Myers Squibb, Longwood Fund
$82MOct 21, 2024
Series B
Arch Venture Partners, Takeda Ventures, Longwood Fund, RA Capital Management, Alta Partners, Atlas Venture, Bristol Myers Squibb
$130MApr 13, 2022
Series A
Atlas Venture, RA Capital Management, Takeda Ventures, Longwood Fund, Alta Partners
$52MOct 21, 2020

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Be Biopharma Headquarters Location

B200 Suite 001, Cambridge, MA, 02139

Loading map…